135 related articles for article (PubMed ID: 33315670)
1. Metastatic Medulloblastoma: 18F-FDG and 68Ga-DOTANOC PET/CT in Response Evaluation.
ArunRaj ST; Kumar A; Kp H; Mohan N; Gupta S; Tripathi M; Bal C
Clin Nucl Med; 2021 May; 46(5):e262-e263. PubMed ID: 33315670
[TBL] [Abstract][Full Text] [Related]
2. 68Ga-DOTANOC PET/CT in Medulloblastoma.
Arunraj ST; Parida GK; Damle NA; Arora S; Reddy S; Chakraborty D; Prabhu M; Tripathi M; Bal C
Clin Nucl Med; 2018 May; 43(5):e145-e146. PubMed ID: 29485447
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors.
Zhou Z; Wang Z; Zhang B; Wu Y; Li G; Wang Z
Front Endocrinol (Lausanne); 2021; 12():727327. PubMed ID: 34539577
[TBL] [Abstract][Full Text] [Related]
4. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of diffuse leptomeningeal metastasis in a treated case of medulloblastoma with F-18 FDG PET/CT.
Tripathi M; Jain N; Jaimini A; Garg G; D'souza MM; Sharma R; Grover RK; Mondal A
Clin Nucl Med; 2009 Aug; 34(8):530-2. PubMed ID: 19617737
[No Abstract] [Full Text] [Related]
6. Comparison of diagnostic efficacy of
Zhang B; He Q; Long Y; Zhang Y; Wang X; Chen Z; Liu J; Zhang X
Front Endocrinol (Lausanne); 2022; 13():962800. PubMed ID: 36213295
[TBL] [Abstract][Full Text] [Related]
7. A rare case of ectopic adrenocorticotropic hormone syndrome caused by a metastatic neuroendocrine tumor of the pancreas detected by 68Ga-DOTANOC and 18F-FDG PET/CT.
Treglia G; Salomone E; Petrone G; Giaccari A; Rindi G; Rufini V
Clin Nucl Med; 2013 Jul; 38(7):e306-8. PubMed ID: 23486330
[TBL] [Abstract][Full Text] [Related]
8. Multifocal extra-adrenal paraganglioma evaluated with different PET tracers: comparison between 18F-FDG, 18F-DOPA and 68Ga DOTANOC PET/CT.
Treglia G; Cardillo G; Stefanelli A; Di Franco D; Enang GN; Giordano A; Rufini V
Clin Nucl Med; 2013 Dec; 38(12):e458-62. PubMed ID: 23486329
[TBL] [Abstract][Full Text] [Related]
9. Warthin Tumor Incidentally Detected on PET/CT Showing Both 68Ga-DOTANOC and 18F-FDG Uptake.
Vaz SC; Marques A; Lourenço J; Galzerano A
Clin Nucl Med; 2021 Feb; 46(2):e118-e120. PubMed ID: 32956121
[TBL] [Abstract][Full Text] [Related]
10. Incidental Finding of Cerebellar Medulloblastoma on 68Ga-DOTATATE PET/CT in a Patient With Appendiceal Carcinoid.
Chan M; Hsiao E
Clin Nucl Med; 2016 Nov; 41(11):886-887. PubMed ID: 27607158
[TBL] [Abstract][Full Text] [Related]
11. Detecting bone marrow metastasis in cerebellar medulloblastoma: value of disease surveillance with FDG-PET in this setting.
Basu S; Gupta T; Jalali R; Shet T
Indian J Cancer; 2011; 48(3):373-4. PubMed ID: 21921346
[No Abstract] [Full Text] [Related]
12. Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT.
Parida GK; Tripathy S; Datta Gupta S; Singhal A; Kumar R; Bal C; Shamim SA
Clin Nucl Med; 2018 Apr; 43(4):248-249. PubMed ID: 29474196
[TBL] [Abstract][Full Text] [Related]
13. Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine Tumors.
Ansquer C; Touchefeu Y; Faivre-Chauvet A; Leux C; Le Bras M; Régenet N; Fleury V; Maucherat B; Senellart H; Guyetant S; Carlier T; Scotet-Cérato E; Rauscher A; Frampas E; Kraeber-Bodéré F
Clin Nucl Med; 2021 Mar; 46(3):181-186. PubMed ID: 33315677
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 68Ga-DOTANOC with 18F-FDG using PET/MRI imaging in patients with pulmonary tuberculosis.
Naftalin CM; Leek F; Hallinan JTPD; Khor LK; Totman JJ; Wang J; Wang YT; Paton NI
Sci Rep; 2020 Aug; 10(1):14236. PubMed ID: 32859979
[TBL] [Abstract][Full Text] [Related]
15. The Combined Interpretation of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Classification System With Prognostic Impact.
Hayes AR; Furtado O'Mahony L; Quigley AM; Gnanasegaran G; Caplin ME; Navalkissoor S; Toumpanakis C
Clin Nucl Med; 2022 Jan; 47(1):26-35. PubMed ID: 34874347
[TBL] [Abstract][Full Text] [Related]
16. 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation.
Christiansen CD; Petersen H; Nielsen AL; Detlefsen S; Brusgaard K; Rasmussen L; Melikyan M; Ekström K; Globa E; Rasmussen AH; Hovendal C; Christesen HT
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):250-261. PubMed ID: 29116340
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor.
Sharma P; Naswa N; Kc SS; Alvarado LA; Dwivedi AK; Yadav Y; Kumar R; Ammini AC; Bal C
Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2194-202. PubMed ID: 25030618
[TBL] [Abstract][Full Text] [Related]
18. Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CT.
Civan C; Isik EG; Simsek DH
Clin Nucl Med; 2021 Apr; 46(4):e212-e213. PubMed ID: 33156050
[TBL] [Abstract][Full Text] [Related]
19. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA
Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285
[TBL] [Abstract][Full Text] [Related]
20. Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor.
Chan M; Schembri GP
Clin Nucl Med; 2017 Feb; 42(2):108-109. PubMed ID: 27997429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]